Effect of a poly(propylene fumarate) foaming cement on the healing of bone defects.

Regeneration of skeletal tissues has been recognized as a new means for reconstruction of skeletal defects. We investigated the feasibility of an injectable and expandable porous implant system for in situ regeneration of bone. Therefore, a composite biodegradable foaming cement based on poly(propylene fumarate) was injected into a critical size defect made in the rat tibia. Animals were divided into two groups comparing the foam in the experimental group against sham-operated animals having a drill hole but no implant in the control group. Eight animals were included in each group. Animals were sacrificed at 1, 3, and 7 weeks postoperatively. Implantation sites were then evaluated with histologic and histomorphometric methods. Results of this study showed that defects did not heal in sham-operated animals. In the experimental group, metaphyseal and cortical defects healed within the first postoperative week by formation of immature woven bone. At the site of the cortical drill hole defect, healing was noted to progress to complete closure by formation of mature bone. Histomorphometry corroborated these findings and showed that metaphyseal bone remodeling peaked at 1 week postoperatively and then decreased as healing of the cortical defect progressed. This suggests that near-complete restoration of the original state of the tibial bone occurred in this animal model supporting the concept of in situ bone regeneration by application of engineered biodegradable porous scaffolds. () ()

[1]  A. Mikos,et al.  In vivo degradation of a poly(propylene fumarate)/beta-tricalcium phosphate injectable composite scaffold. , 1998, Journal of biomedical materials research.

[2]  S. L. Bifano,et al.  Preliminary evaluation of hydroxyapatite cement as an augmentation device in the edentulous atrophic canine mandible. , 1998, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[3]  H. Rubash,et al.  Pathogenesis of bone loss after total hip arthroplasty. , 1998, The Orthopedic clinics of North America.

[4]  M. Richter,et al.  Human immunodeficiency virus activity in rib allografts. , 1998, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[5]  A. Reddi,et al.  Role of morphogenetic proteins in skeletal tissue engineering and regeneration , 1998, Nature Biotechnology.

[6]  B. Mealey,et al.  Hydroxyapatite cement implant for regeneration of periodontal osseous defects in humans. , 1998, Journal of periodontology.

[7]  C. Engh,et al.  Treatment of Pelvic Osteolysis Associated with a Stable Acetabular Component Inserted without Cement as Part of a Total Hip Replacement* , 1997, The Journal of bone and joint surgery. American volume.

[8]  A. Mikos,et al.  In vitro degradation of a poly(propylene fumarate)/β-tricalcium phosphate composite orthopaedic scaffold , 1997 .

[9]  W C Hayes,et al.  In vitro degradation of a poly(propylene fumarate)-based composite material. , 1996, Biomaterials.

[10]  C T Laurencin,et al.  Tissue engineered bone-regeneration using degradable polymers: the formation of mineralized matrices. , 1996, Bone.

[11]  W. Enneking,et al.  Immunologic Responses in Human Recipients of Osseous and Osteochondral Allografts , 1996, Clinical orthopaedics and related research.

[12]  Antonios G. Mikos,et al.  Bone tissue engineering , 1995, Nature Medicine.

[13]  W. Tomford,et al.  Transmission of disease through transplantation of musculoskeletal allografts. , 1995, The Journal of bone and joint surgery. American volume.

[14]  D. Wise,et al.  Analysis of a vinyl pyrrolidone/poly(propylene fumarate) resorbable bone cement. , 1995, Journal of biomedical materials research.

[15]  W. Hayes,et al.  The ingrowth of new bone tissue and initial mechanical properties of a degrading polymeric composite scaffold. , 1995, Tissue engineering.

[16]  R. A. Forster,et al.  Alternatives to Autogenous Bone Graft: Efficacy and Indications , 1995, The Journal of the American Academy of Orthopaedic Surgeons.

[17]  C. Migliaresi,et al.  Polymerization kinetics, glass transition temperature and creep of acrylic bone cements. , 1994, Biomaterials.

[18]  A. Levey,et al.  Low risk of liver disease after tissue transplantation from donors with HCV , 1993, The Lancet.

[19]  A. Renshaw,et al.  Antibiotic‐loaded biodegradable bone cement for prophylaxis and treatment of experimental osteomyelitis in rats , 1993, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[20]  D. Robertson,et al.  Bone loss in the distal anterior femur after total knee arthroplasty. , 1990, Clinical orthopaedics and related research.

[21]  M. Ferraro,et al.  Frozen musculoskeletal allografts. A study of the clinical incidence and causes of infection associated with their use. , 1990, The Journal of bone and joint surgery. American volume.

[22]  C. Sledge,et al.  Biochemical and histological evaluation of the synovial-like tissue around failed (loose) total joint replacement prostheses in human subjects and a canine model. , 1990, Biomaterials.

[23]  J. Shuster,et al.  Prevention of infection after total joint replacement. Experiments with a canine model. , 1988, The Journal of bone and joint surgery. American volume.

[24]  M. Gebhardt,et al.  Infection in bone allografts. Incidence, nature, and treatment. , 1988, The Journal of bone and joint surgery. American volume.

[25]  J. Shuster,et al.  The influence of skeletal implants on incidence of infection. Experiments in a canine model. , 1985, The Journal of bone and joint surgery. American volume.

[26]  H. Mankin,et al.  Immunogenicity of frozen osteoarticular allografts. , 1981, Transplantation Proceedings.

[27]  M. Goldman,et al.  A study of the clinical incidence of infection in the use of banked allograft bone. , 1981, The Journal of bone and joint surgery. American volume.

[28]  W. Hayes,et al.  Bone compressive strength: the influence of density and strain rate. , 1976, Science.

[29]  S. Haas,et al.  A proposed specification for acrylic bone cement. , 1975, Journal of biomedical materials research.

[30]  S. Haas,et al.  A characterization of polymethylmethacrylate bone cement. , 1975, The Journal of bone and joint surgery. American volume.

[31]  W. Maloney,et al.  Osteolysis: cause and effect. , 1998, Instructional course lectures.

[32]  W. Maloney,et al.  Osteolysis: surgical treatment. , 1998, Instructional course lectures.

[33]  L Cristofolini,et al.  A critical analysis of stress shielding evaluation of hip prostheses. , 1997, Critical reviews in biomedical engineering.

[34]  A. Reddi,et al.  Tissue engineering, morphogenesis, and regeneration of the periodontal tissues by bone morphogenetic proteins. , 1997, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[35]  J. E. Mayer,et al.  Tissue engineering scaffolds using superstructures. , 1996, Biomaterials.

[36]  W C Hayes,et al.  Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. , 1996, Biomaterials.

[37]  C. Rivard,et al.  [Bio-absorbable synthetic polyesters and tissue regeneration. A study of three-dimensional proliferation of ovine chondrocytes and osteoblasts]. , 1996, Annales de chirurgie.

[38]  C. Engh,et al.  Producing and avoiding stress shielding. Laboratory and clinical observations of noncemented total hip arthroplasty. , 1992, Clinical orthopaedics and related research.